GeneOne Life Science, Inc. (KRX:011000)
South Korea · Delayed Price · Currency is KRW 2,015.00
+48.00 (2.44%)
Feb 5, 2026, 3:30 PM KST
GeneOne Life Science Market Cap
GeneOne Life Science has a market cap or net worth of 167.59 billion as of February 4, 2026. Its market cap has decreased by -22.53% in one year.
Market Cap
167.59B
Enterprise Value
195.27B
Revenue
30.90B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,015.00
Market Cap Chart
Since August 30, 1995, GeneOne Life Science's market cap has increased from 3.40B to 167.59B, an increase of 4,829.10%. That is a compound annual growth rate of 13.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 167.59B | 0.41% |
| Dec 30, 2025 | 166.91B | -1.14% |
| Dec 30, 2024 | 168.84B | -24.04% |
| Dec 28, 2023 | 222.27B | -59.85% |
| Dec 29, 2022 | 553.65B | -55.74% |
| Dec 30, 2021 | 1.25T | 30.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Helixmith | 284.11B |
| HLB Therapeutics | 251.87B |
| EASY BIO,Inc. | 249.11B |
| Genexine | 215.12B |
| MedPacto | 213.53B |
| Macrogen | 199.37B |
| ENCell | 189.33B |
| IMB Dx | 130.65B |